103 related articles for article (PubMed ID: 107146)
1. Effect of human serum thymic factor on immature T lymphocytes in acute leukemia and other hematologic malignancies.
Cavdar AO; Ozger Topuz U; Erten J; Losio M; Erten M; Astaldi G
Isr J Med Sci; 1978 Dec; 14(12):1216-20. PubMed ID: 107146
[TBL] [Abstract][Full Text] [Related]
2. E-rosette forming lymphocytes in acute leukemia before and after cell incubation with human serum thymic factor.
Ozger Topuz U; Okçuoglu Cavdar A; Astaldi G
Boll Ist Sieroter Milan; 1977 Nov; 56(5):449-56. PubMed ID: 304352
[TBL] [Abstract][Full Text] [Related]
3. [Use of thymus hormone in the demonstration of acute T-null cell lymphocytic leukemia].
Ozger Topuz U; Astaldi G; Cavdar A
Minerva Med; 1978 Apr; 69(18):1275-80. PubMed ID: 307199
[TBL] [Abstract][Full Text] [Related]
4. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid-hormone-related peptide in hematologic malignancies.
Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
[TBL] [Abstract][Full Text] [Related]
6. Acute leukaemia: cell markers and thymic factor on E-rosette frequency.
Astaldi G; Topuz UO; Brunelli MA; Cavdar A; Bagnara GP; Erten J; Ertem U
Haematologia (Budap); 1978-1979; 12(1-4):127-34. PubMed ID: 317059
[No Abstract] [Full Text] [Related]
7. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
9. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
10. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
Meier EC; Grob PJ
Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059
[No Abstract] [Full Text] [Related]
11. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
[TBL] [Abstract][Full Text] [Related]
12. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
13. Thymic humoral factor in the assessment of T lymphocytics in a patient with T cell chronic lymphocyte leukemia.
Douer D; Shohat B; Djaldetti M; Trainin N; Pinkhas J
Isr J Med Sci; 1978 Aug; 14(8):870-5. PubMed ID: 29860
[TBL] [Abstract][Full Text] [Related]
14. Human serum thymic factor in detecting acute T cell leukemia.
Ozger Topuz U; Cavdar AO; Astaldi G
Bibl Haematol; 1978; 45():152-5. PubMed ID: 311636
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
16. Hormonal changes in patients with haematological malignancies.
Pavelic K; Pekic B; Gabrilovac J; Bratic-Mikes V; Boranic M
Biomedicine; 1981 Nov; 35(6):181-4. PubMed ID: 6279194
[TBL] [Abstract][Full Text] [Related]
17. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease.
Chisesi T; Capnist G; Rancan L; Pellizzari G; Vespignani M
J Biol Regul Homeost Agents; 1988; 2(4):193-8. PubMed ID: 3074627
[TBL] [Abstract][Full Text] [Related]
18. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
Michalevicz R; Many A; Ramot B; Trainin N
Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
[TBL] [Abstract][Full Text] [Related]
19. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the immunological indices of the peripheral blood and lymph nodes in lymphogranulomatosis in children].
Voĭtenkov BO; Gavrilenkova LP
Vopr Onkol; 1985; 31(7):83-7. PubMed ID: 3875182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
